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Differential Increase in Taurine Levels by Low-Dose
Ethanol in the Dorsal and Ventral Striatum Revealed
by Microdialysis With On-Line Capillary
Electrophoresis
A. Smith, C. J. Watson, K. J. Frantz, B. Eppler, R. T. Kennedy, and J. Peris
Ethanol increases taurine efflux in the nucleus accumbens or ventral striatum (VS), a dopaminergic
terminal region involved in positive reinforcement. However, this has been found only at ethanol doses
above 1 g/kg intraperitoneally, which is higher than what most rats will self-administer. We used a sensitive
on-line assay of microdialysate content to test whether lower doses of ethanol selectively increase taurine
efflux in VS as opposed to other dopaminergic regions not involved in reinforcement (e.g., dorsal striatum;
DS). Adult male rats with microdialysis probes in VS or DS were injected with ethanol (0, 0.5, 1, and 2 g/kg
intraperitoneally), and the amino acid content of the dialysate was measured every 11 sec using capillary
electrophoresis and laser-induced fluorescence detection. In VS, 0.5 g/kg ethanol significantly increased
taurine levels by 20% for 10 min. A similar increase was seen after 1 g/kg ethanol, which lasted for about
20 min after injection. A two-phased taurine efflux was observed with the 2.0 g/kg dose, where taurine was
increased by 2-fold after 5 min but it remained elevated by 30% for at least 60 min. In contrast, DS exhibited
much smaller dose-related increases in taurine. Glycine, glutamate, serine, and -aminobutyric acid were
not systematically affected by lower doses of ethanol; however, 2 g/kg slowly decreased these amino acids
in both brain regions during the hour after injection. These data implicate a possible role of taurine in the
mechanism of action of ethanol in the VS. The high sensitivity and time resolution afforded by capillary
electrophoresis and laser-induced fluorescence detection will be useful for detecting subtle changes of
neuronally active amino acids levels due to low doses of ethanol.
Key Words: Ethanol, Taurine, Ventral Striatum, On-Line Microdialysis, Capillary Electrophoresis,
Amino Acids.
THE ABILITY OF ethanol to increase dopamine signal-ing in the nucleus accumbens or ventral striatum (VS)
is thought to be one of the possible neurobiological mech-
anisms for the positive reinforcement caused by ethanol
consumption (Brodie et al., 1990; Brodie and Appel, 1998;
Nurmi et al., 1998; Yim et al., 1998: Yoshimoto et al.,
1991). Support for this possibility is that disruption of
ethanol-induced dopamine efflux via a number of different
approaches reduces alcohol self-administration (El-Ghundi
et al., 1998; Gonzales and Weiss, 1998; Phillips et al., 1998).
Acamprosate (a calcium homolog of the naturally-occurring
amino acid, taurine) and homotaurine (a taurine precursor)
are drugs that decrease both ethanol self-administration and
ethanol-induced dopamine efflux (Olive et al., 2002); how-
ever, the mechanism for this effect is not known.
Ethanol affects many different neural systems such as
activating inhibitory -aminobutyric (GABA) receptors
(Allan and Harris, 1987; Harris, 1999; Proctor et al., 2003)
and inhibiting excitatory glutamate receptors (Fitzgerald
and Nestler, 1995; Lovinger et al., 1989). Similar to ethanol,
taurine has been shown to positively modulate GABA re-
ceptor function (Bureau and Olsen, 1991; Del Olmo et al.,
2000; Liljequist, 1993; Quinn and Harris, 1995) and glycine
receptor function (Han et al., 2001; Mori et al., 2002;
Sergeeva and Haas, 2001). Changes in the levels of neuro-
transmitters affected by ethanol could lead to the patho-
logic state of alcoholism (Nevo and Hamon, 1995; Tsai,
1998). In the nucleus accumbens, acute ethanol does not
alter GABA efflux (Dahchour et al., 1994, 1996; De Witte
et al., 1994; Heidbreder and De Witte, 1993; Moghaddam
and Bolinao, 1994), but taurine levels are increased in a
dose-dependent manner by ethanol (Dahchour et al.,
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1994), and this effect is enhanced by repeated ethanol
exposure (Dahchour et al., 1994, 1996; Dahchour and De
Witte, 2000a). In contrast, acute low doses of ethanol have
been shown by some to increase glutamate efflux, whereas
higher doses decrease glutamate efflux (Dahchour et al.,
1994, 1996; De Witte et al., 1994; Heidbreder and De
Witte, 1993; Moghaddam and Bolinao, 1994). Interestingly,
glutamate receptor agonists can also increase taurine re-
lease (Lehmann et al., 1985; Magnusson et al., 1991; Oja
and Saransaari, 2000; Saransaari and Oja, 2000). Taurine
alters the reinforcing properties of ethanol (Aragon and
Amit, 1993; Quertemont et al., 1998), and rats genetically
selected for differences in ethanol self-administration ex-
hibit alterations in both ethanol-induced taurine and dopa-
mine efflux in the nucleus accumbens (Dahchour et al.,
2000; Piepponen et al., 2002; Quertemont et al., 2002).
Although this evidence is suggestive for a role of taurine
in ethanol reinforcement, significant gaps exist in our
knowledge of how this can occur. Not all genetically se-
lected strains exhibit differential ethanol-induced dopa-
mine efflux (Kiianmaa et al., 1995; Yoshimoto et al., 1992)
nor have they all been tested for alterations in taurine
efflux. Also, self-administering animals normally ingest
around 0.5 g/kg of ethanol, yet taurine levels have not been
demonstrated to be altered by such low doses. In addition,
the temporal pattern of taurine efflux relative to ethanol
administration has not been sufficiently characterized to
determine if it could play a primary role in mediating the
reinforcing effects of ethanol. Finally, the selectivity of
taurine changes has not been directly compared across
brain regions. If ethanol affects taurine in a similar fashion
throughout the brain, a specific neuronal role of taurine in
mediating the reinforcing effects of ethanol is less likely.
Most of the prevailing in vivo data have used microdialy-
sis coupled with HPLC-based analysis in which samples are
collected every 10 to 15 min, precluding temporal resolu-
tion sufficient to determine the relationship between the
release of taurine with that of dopamine, GABA, or gluta-
mate. Capillary electrophoresis coupled with laser-induced
fluorescence detection (CE-LIF) has recently been adapted
to measure in vivo extracellular levels of amino acids with
much higher temporal resolution (Bowser and Kennedy,
2001; Lada and Kennedy, 1996), which provides the means
to examine neuronal processes (Lada et al., 1998). A po-
tentially powerful method, microdialysis with rapid on-line
CE-LIF, had not previously been used to measure the
effects of ethanol in freely moving animals.
METHODS
Animals
Male Sprague Dawley® rats, 70 to 90 days of age (Harlan, Indianapolis,
IN), weighing 250 to 350 g were housed two to three per cage in a
temperature- and humidity-controlled environment with a 12 hr normal
phase light/dark cycle. All testing and training were conducted during the
light phase. The subjects had ad libitum access to food and water through-
out the experiment unless otherwise indicated. All procedures were con-
ducted in strict adherence to the National Institute of Health Guide for the
Care and Use of Laboratory Animals.
Chemicals
NaCl, CaCl2, KCl, MgSO4, o-phthaldialdehyde (OPA), -mercaptoethanol
(BME), sodium tetraborate, and hydroxypropyl--cyclodextrin (HPBCD)
were purchased from Sigma Chemical (St. Louis, MO). Ethanol (95%)
was obtained from Aaper Alcohols and Chemicals (Shelbyville, KY).
Saline was purchased from Baxter Healthcare Corporation (Deerfield,
IL).
Surgeries
Each rat was anesthetized with 86 mg/kg ketamine and 13 mg/kg
xylazine and placed in a stereotaxic apparatus for surgical implantation of
a guide cannula. The guide cannula (21 gauge; Plastics One, Roanoke,
VA) was positioned above the left side of the dorsal striatum (DS) or VS
using the following coordinates: DS, 0.8 anteroposterior, 3.0 lateral to
bregma, 4.0 dorsoventral to skull; VS, 1.6 anteroposterior, 1.7 lat-
eral, 6.2 dorsoventral. The guide cannula was secured to the skull with
dental cement anchored by three stainless steel screws. After surgery, each
rat was housed separately and allowed to recover for 5 to 7 days with daily
handling to ensure patency of the guide cannula and to minimize handling
stress during subsequent measurements.
Microdialysis
Microdialysis probes (outer diameter 270 m; active length 2 mm for
the VS and 3 mm for DS; cellulose membrane, 13,000 molecular weight
cutoff) were constructed by the method of Pettit and Justice (1991). On
the day of the experiment, each rat was lightly anesthetized with halothane
and moved into the dialysis cage, and the guide cannula was cleared for
insertion of the dialysis probe. The probe was perfused with artificial
cerebrospinal fluid (ACSF; 145 mM NaCl, 2.8 mM KCl, 1.2 mM MgSO4,
1.2 mM CaCl2) at 1 l/min. After probe insertion, each rat was placed in
a clear polyurethane test box (9 3/8 in.  18 in.  10 in. deep) with
bedding, water bottle, and food. After this procedure, samples were taken
every 11 sec for 4 to 6 min (20–30 samples), and this was repeated every
15 min for the first 90 min after probe implantation. About 2 hrs after
probe insertion, saline (1 ml/kg body weight, 0.9% NaCl) was injected
intraperitoneally and 285 samples (55 min) were taken. Subsequent injec-
tions of ethanol (20% w/v in saline, intraperitoneally) occurred in the
following order at 1 hr intervals: 0.5 g/kg, 1 g/kg, and 2 g/kg. After each
injection, 285 samples were collected. The amino acid concentrations in
dialysate samples were analyzed on-line by CE-LIF. A calibration curve
was generated either before or after the experiment by placing the tip of
the dialysis probe in three different concentrations of a standard solution
containing glutamate, aspartate, GABA, taurine, dopamine, serine, and
glycine and collecting 30 samples each. The mean relative fluorescence of
all samples was converted to concentration through the use of the cali-
bration curve (a plot of peak height versus standard concentration).
After microdialysis, rats were killed by rapid decapitation. Brains were
removed and frozen at 20°C, and 30 m sections were taken to verify
probe placement.
CE-LIF
Amino acids were measured by CE-LIF using the procedure estab-
lished by Bowser and Kennedy (2001). Primary amine moieties in the
dialysate were derivatized on-line by mixing with a 1 l/min stream of
OPA solution (10 mM OPA, 40 mM BME, 36 mM borate, 0.81 mM
HPBCD, 10% methanol v/v, pH 9.5) with a reaction time of approximately
1.5 min. The reaction time did not limit the temporal resolution of the
measurement; however, it did induce a 3 to 5 min delay between changes
occurring at the dialysis probe and their detection by the CE system.
Samples of the dialysate were injected onto the capillary using a flow-gate
interface as follows. The outlet of the reaction capillary was aligned with
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the inlet of the CE separation capillary (10 cm long, 10 m inner diameter,
150 m outer diameter, fused-silica) in a Plexiglas block, leaving a gap of
approximately 30 m. A 1 ml/min cross-flow was applied between the
capillaries, which carried the sample solution to waste. To inject a plug of
sample, the cross-flow was stopped for 1 sec allowing the sample to fill the
gap between capillaries, and the voltage was then raised to 2 kV for 100
msec. After injection, the gating cross-flow was resumed to wash excess
dialysate to waste, and the separation voltage was ramped from 2 kV to 20
kV over 500 msec using a CZE1000R high-voltage power supply (Spell-
man High Voltage, Hauppauge, NY).
The OPA-labeled amino acids were detected using LIF in a sheath-flow
detector cell. The outlet of the separation capillary was inserted into a 2
mm square outer diameter, 200 m square inner diameter quartz cuvette
(Mindrum Precision, Rancho Cucamonga, CA). Grinding the outlet of the
separation capillary to a point reduced the dead volume at the detection
point. Sheath buffer (40 mM borate, pH  9.5) was siphoned around the
outside of the separation capillary. This arrangement reduces the back-
ground signal caused by laser scatter as well as background fluorescence
caused by impurities in the fused silica. Fluorescence was excited using the
351 nm line (20 mW total UV) of an argon-ion laser (Enterprise II 622;
Coherent Laser Group, Santa Clara, CA) focused onto the analytes using
a 1X fused silica lens (Newport Corp., Irvine, CA). Emission was collected
at a 90° angle using a 60X, 0.7 N.A. long-working distance objective
(Universe Kogaku, Oyster Bay, NY), spatially filtered using an iris, passed
through a 450  25 nm bandpass (Melles Groit, Irvine, CA), and collected
on a photomultiplier tube (PMT, R1477; Hamamatsu, Bridgewater, NJ).
Current from the PMT was amplified, filtered (10 msec rise time), and
sampled using LabView 5.0 (National Instruments, Austin TX). Sample
electropherograms are shown in Fig. 1 after saline (panel A) or ethanol
(panel B) injections.
HPLC
For some experiments, dialysate was collected at 15 min intervals (flow
rate  2 l/min) and frozen, and then taurine content was measured at a
later date using HPLC with electrochemical detection (Dawson and Wal-
lace, 1992). Samples were derivatized before HPLC by reacting 20 l of
dialysate and 180 l of mobile phase with 175 l of a 9 mM OPA/0.5%
BME solution in a 0.1 M disodium borate solution (pH 10.0) for exactly 2
min. The derivatization reaction was terminated by adding 25 l 0.4 M
iodoacetamide, which also served to diminish electrochemical interference
by OPA. Derivatized dialysate (250 l) was injected onto a reversed-phase
column (Microsorb-MV, 4.6 mm inner diameter  10 cm, C18 with 3 m
packing material; Rainin, Woburn, MA), and mobile phase was pumped at
0.7 ml/min (PM-11, Bioanalytical Systems, West Lafayette, IN). Derivat-
ized taurine was detected using an Ag/AgCl reference electrode and a
glassy carbon working electrode at an applied voltage of 0.725 V (LC-4B,
Bioanalytical Systems, West Lafayette, IN). Sample taurine concentra-
tions were calculated by a Hewlett Packard integrator (model 3390A,
Avondale, PA) based on external standards prepared and injected daily.
Dialysate Ethanol Determinations
Dialysate ethanol content was measured using headspace gas chroma-
tography with an automated solid phase microextraction (SPME) proce-
dure. A Varian 2800 gas chromatograph was equipped with a
Supelcowax-10 megabore column (15 mm  0.53 mm; 0.5 m film). The
injector was set to 175°C, the column oven was 65°C, and the flame
ionization detector was 220°C. Samples were heated to 65°C for 15 min
before analysis. The SPME of the headspace was carried out in an 8200
autosampler using 3 min absorption and 2 min desorption. The SPME
fiber was coated with carboxenpolydimethylsiloxane (75 m). Ethanol
concentrations were quantified by comparison to external standards. The
lowest standard run routinely was 0.3125 mM, which gave a signal to noise
ratio of 10.
Data Analysis
The first 20 samples collected in each CE-LIF experiment (preinjec-
tion) were used to calculate a baseline of 100%. Subsequent data were
expressed as a percent of this baseline and are depicted in each figure as
the mean  SEM. For statistical purposes, the mean of each five samples
was calculated and subjected to a three-way ANOVA with unweighted-
means solution for unequal n using brain region, dose, and time period as
variables for each analyte. To follow up significant time interactions, data
were divided into first 20 min, second 20 min, and last 12 min after
injection and analyzed separately. A significance level of p  0.05 was used
for all statistical analyses. Only those subjects with accurate probe place-
ments (Fig. 2) were included in the analysis.
RESULTS
Acute injection of ethanol increased taurine levels in the
DS and VS in a dose-dependent manner; however, the VS
displayed a higher sensitivity to ethanol, responding with
greater magnitude and to lower doses than did DS (Fig. 3).
In the VS (Fig. 3A), the largest increase in taurine levels
Fig. 1. Representative electropherograms of dialysate from VS collected under
basal microdialysis conditions or from the same animal after it received 2.0 g/kg
ethanol as described for Fig. 3. Insets are close-ups of the electropherogram to
facilitate viewing of the glutamate, aspartate, and GABA peaks. Note the selective
increase in only the taurine peak caused by ethanol.
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(90  15% above baseline) occurred 5 to 15 min after the
2 g/kg injection, after which taurine levels gradually stabi-
lized to 30  7% above basal until the end of the sampling
period. The 1 g/kg dose increased taurine levels for about
15 min with a maximal increase of 28  8%. A slightly
lower magnitude of increase (20  9%) was observed after
the 0.5 g/kg dose with a somewhat shorter duration. There
was a slight elevation in taurine levels for 5 min after saline
injection, never reaching a 10% increase from basal values.
The DS was less sensitive to the ethanol injection (Fig.
3B). The highest dose of ethanol maximally increased
taurine levels by only 25  9% above baseline for 30 min.
Similarly, 0.5 and 1 g/kg ethanol intraperitoneally in-
creased taurine by a maximum of only 15  5% above
baseline levels. The saline injection also increased tau-
rine levels by 15  5% but only for about 5 min, after
which taurine levels returned to a stable baseline for the
duration of sampling.
These observations were supported by the results of a
three-way ANOVA as follows. An overall significant brain
region  dose  time interaction [F(156,1560)  1.85, p 
0.001] was detected. During the first 20 min of sampling,
there was a significant brain region  dose  time inter-
action [F(57,570)  3.65, p  0.001], which was primarily
due to a significant region  time interaction at the 2 g/kg
dose [F(19,190)  6.17; p  0.001] but not after any of the
other injections. There were significant dose  time inter-
actions for both the VS [F(57,342)  11.6, p  0.001] and
DS [F(57,228)  3.43, p  0.001] and significant main
effects of time after all injections in both brain regions [VS,
F(19,114) ranged from 2.22 to 21.6; DS, F(19,76) ranged
from 2.91 to 6.11; p at least  0.05]. During the 20 to 40 min
after injection, ANOVA revealed only significant two-way
interactions of region  dose [F(3,30)  4.52, p  0.01] and
Fig. 2. Probe placements shown in coronal sections from VS (A) or DS (B). The
coronal sections shown are from Paxinos and Watson (1997).
Fig. 3. Ethanol-induced changes in taurine. The change in taurine levels in
microdialysate from (A) the VS (n  7) and (B) the DS (n  5) of rats after saline
or 0.5, 1.0, or 2.0 g/kg intraperitoneal ethanol injections given in a series of
injections. Microdialysate was sampled for 1 hr after each injection. The injection
occurred at the start of each 1 hr sampling period, but there was approximately
a 5 min delay for dialysate to travel from the probe tip to the flow-gate. Data were
calculated as a percent of the mean  SEM relative fluorescence of the first 20
samples (basal efflux, see Fig. 7).
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region  time [F(19,190)  5.63, p  0.001], which was
primarily due to a significant main effect of dose only in the
VS [F(3,18)  17.5, p  0.001]. Follow-up analyses indi-
cated a significant main effect of region after the 2 g/kg
dose [F(1,10)  6.11; p  0.05] but not after saline or 0.5 or
1 g/kg ethanol. During the last 12 min after injection, the
interaction between brain region and dose was no longer
significant [F(3,30)  2.74, p  0.06].
When the effect of the same series of ethanol injections
on glutamate levels was measured and compared with tau-
rine, a very different time course of changes was seen. That
is, no effect occurred at any dose until at least 10 to 15 min
after injection in both brain regions (Fig. 4). At this point,
2 g/kg ethanol began to decrease glutamate levels in both
the DS and the VS by 10% to 15%, whereas 0.5 g/kg
ethanol increased glutamate levels, particularly in the DS.
Specifically, 0.5 g/kg increased glutamate levels in the DS
(Fig. 4B) starting at 20 min to reach a maximum increase of
60  30% above baseline by the end of the sampling
period. However, this large magnitude increase occurred in
only two of five subjects, explaining the large SEMs. The
0.5 g/kg dose of ethanol also caused a small increase in
glutamate in the VS, which was primarily due to larger
magnitude increases in three of seven rats tested. There
was no change in glutamate levels after the saline or 1 g/kg
injection for either region.
These observations were supported by an overall signif-
icant brain region  dose  time interaction [F(156,1560)
 1.54, p  0.001]. The glutamate data from the first 20,
second 20, and last 12 min of sampling were subjected to a
three-way ANOVA. During the first 20 min after injection,
there was an overall dose  time interaction [F(57,570) 
2.15, p  0.001], which was due to a main effect of time
after the 2 g/kg injection [F(19,190)  10.8, p  0.001].
There was no significant effect of brain region. On the
other hand, there were significant region  dose  time
interactions during the second 20 min [F(57,570)  1.95, p
 0.001] and last 12 min [F(33,330)  1.61, p  0.05], which
were due to an effect of dose in the DS [F(3,12)  4.20, p
 0.05] but not the VS and an effect of time after only the
0.5 and 2 g/kg injections [F(19,190)  1.95 and 2.02, re-
spectively, p  0.01].
Acute ethanol slowly decreased glycine levels in a dose-
related manner in both the VS and the DS (Fig. 5). The 2
g/kg dose maximally decreased glycine by 25–30% after 45
min whereas 1 g/kg decreased glycine by 10% to 15% over
time, and neither saline nor 0.5 g/kg affected glycine levels.
Overall, there was no significant effect of brain region 
dose  time [F(156,1560)  0.67, p  0.99]. However,
there was a significant dose  time interaction [F(57,570)
 2.74, p  0.001] during the first 20 min after injection
and significant dose main effects during the second 20 min
[F(3,30)  6.40, p  0.01] and the last 12 min [F(3,30) 
5.43, p  0.01]. There was a region  time interaction
during the first 20 min [F(57,570)  3.65, p  0.001], which
was due to a greater overall effect of time in the VS than
the DS.
Ethanol slowly decreased serine levels by about 10% to
20% in the VS and DS (Fig. 6), especially at the higher
doses tested. These observations were supported by a sig-
nificant overall brain region  dose  time interaction
[F(156,1560)  1.28, p  0.05]. There was a significant dose
 time interaction [F(57,570)  3.19, p  0.001] during the
first 20 min after injection and significant dose effects
during the second 20 min [F(3,30)  4.20, p  0.05] and the
last 12 min [F(3,30)  6.12, p  0.01]. There were no main
effects or interactions involving brain region. There were
no systematic effects of ethanol on GABA levels in the VS
and a small inhibitory effect (about 15%) of the highest
ethanol dose in the DS (data not shown). However,
ANOVA of these data did not indicate any significant main
effects or interactions during any of the time periods after
injection.
To determine whether there were residual effects of the
repeated injections of saline and 0.5 g/kg, 1 g/kg, and 2 g/kg
ethanol, basal levels of amino acids in dialysate were com-
Fig. 4. Ethanol-induced changes in glutamate. Glutamate levels in microdia-
lysate from (A) the VS (n  7) and (B) the DS (n  5) of rats after saline or 0.5, 1.0,
or 2.0 g/kg intraperitoneal ethanol injections given in a series of injections.
Microdialysate was sampled and data calculated as described for Fig. 3.
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pared. Figure 7 is the mean amino acid concentration
calculated from the first 20 11-sec samples (i.e., the first 3.5
min of sampling) for taurine, glycine, glutamate, and
GABA in microdialysate from the VS (Fig. 7A) and DS
(Fig. 7B) after each injection. Basal values for the treat-
ments in the VS did not significantly deviate from one
treatment to the next [F(3,18)  1.0, nonsignificant for all
analytes]. Likewise, the DS basal values for the amino acids
measured did not significantly change from treatment to
treatment [F(3,12) ranged from 0.44 to 1.23, nonsignificant
for all analytes]. It was also apparent from these data that
all amino acids had reached stable levels by 2 hrs after
probe insertion.
To compare the sensitivity of the CE-LIF assay to con-
ventional microdialysis methods, we injected rats with sa-
line or 1 g/kg ethanol (in a counterbalanced fashion) and
collected dialysate samples from DS every 15 min that were
subsequently analyzed for taurine using HPLC. Taurine
levels in the striatum were significantly elevated by both
saline and ethanol injections (Fig. 8). The 1 g/kg dose of
ethanol increased taurine above basal levels at the 15 min
interval, as confirmed by a significant main effect of time
[F(17,85)  3.39, p  0.001]. The saline injection also
increased taurine above basal levels at the 15 min interval
[F(5,25)  2.82, p  0.05]. However, there was no signifi-
cant main effect or interaction involving the type of injec-
tion (saline versus ethanol).
To compare the dialysate ethanol concentrations be-
tween the two types of ethanol exposure (four cumulative
escalating doses versus one 1 g/kg dose), we compared
dialysate ethanol levels in the animals used in Fig. 8 with
those of an additional three animals experiencing the series
of cumulative injections as used in Figs. 3 through 7 but
with dialysate collected every 10 min. The 1 g/kg ethanol
injection, when given alone, increased brain dialysate eth-
anol levels to about 10 mM within the first 15 min after
injection, which then took approximately 3 hr to return to
basal levels (Fig. 9 and data not shown). The first injection
of 0.5 g/kg ethanol increased brain ethanol levels to about
7 mM, which then decreased to about 4 mM just before the
second injection of 1.0 g/kg. This injection raised brain
dialysate ethanol to about 14 mM, where it remained fairly
Fig. 5. Ethanol-induced decreases in glycine. The change in glycine levels in
microdialysate from (A) the VS (n  7) and (B) the DS (n  5) of rats after saline
or 0.5, 1.0, or 2.0 g/kg intraperitoneal ethanol injections given in a series of
injections. Microdialysate was sampled and data calculated as in Fig. 3.
Fig. 6. Ethanol-induced decreases in serine. Serine levels in microdialysate
from (A) the VS (n  7) and (B) the DS (n  5) of rats after saline or 0.5, 1.0, or 2.0
g/kg intraperitoneal ethanol injections given in a series of injections. Microdialy-
sate was sampled and data were calculated as described in Fig. 3.
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constant until the final ethanol injection of 2 g/kg. This
injection further raised brain ethanol levels to about 30
mM, where they remained stable for the duration of the
experiment.
To ascertain whether the ability of ethanol to affect
amino acid levels was a direct effect of ethanol on the cells
surrounding the microdialysis probe, ethanol was perfused
directly into the VS. In this CE-LIF experiment, a series of
concentrations (50 mM, 500 mM, 1 M) of ethanol was
perfused (1 L/min) by reverse dialysis into the VS and
samples were collected every 11 sec for 30 min at each
concentration (Fig. 10). Increasing the concentration of
ethanol in the ACSF had no effect on taurine levels but
caused a concentration-dependent increase in both gluta-
mate and glycine levels by about 30% to 40% above base-
Fig. 7. Basal dialysate levels of amino acids. The mean concentrations for
taurine, glycine, glutamate, and GABA in microdialysate under basal conditions
from (A) the VS (n  7) and (B) the DS (n  5) of rats before saline or 0.5, 1.0, or
2.0 g/kg intraperitoneal ethanol injections given in a series of injections. The mean
basal values were calculated from the first 20 samples at the beginning of each 1
hr sampling period. There was no effect of prior injections on the basal levels of
any analytes measured.
Fig. 8. HPLC determination of ethanol-induced taurine efflux. The level of
taurine in microdialysis samples from DS of rats for 1 hr before and after a saline
or 1 g/kg intraperitoneal ethanol injection. Samples were collected every 15 min
and subjected to HPLC analysis. Data are expressed as a percent of the mean
taurine level in the two samples before injection (1.10  0.25 M for saline; 1.14
 0.26 M for ethanol). Shown are mean  SEM for n  7.
Fig. 9. Brain dialysate ethanol levels. The level of ethanol in microdialysis
samples from DS after one injection of ethanol (1 g/kg) or after a series of ethanol
injections as follows: 0.5 g/kg at 1 min, 1.0 g/kg at 61 min, and 2.0 g/kg at 121
min. Shown are mean  SEM for n  3–5.
Fig. 10. Taurine, glutamate, glycine, and serine levels after direct exposure to
different concentrations of ethanol via reverse dialysis. Data are expressed as a
percent of the mean analyte concentration in the 15 samples (3 min) before
changing ACSF ethanol content (taurine  3.9  1.6 M, glutamate  0.2  0.1
M, glycine  2.7  1.0 M, serine  2.1  0.8 M). Shown are mean  SEM
for n  4.
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line. On the other hand, 50 and 500 mM ethanol tended to
decrease serine levels. However, none of the effects caused
by including ethanol in the ACSF resulted in amino acid
levels that were significantly different from levels under
control conditions.
DISCUSSION
These results provide novel support for the hypothesis
that ethanol exposure causes a selective interaction with
taurine levels in different regions of the brain. For the first
time, increases in taurine were observed at doses that
animals will self-administer and at a greater magnitude in
brain regions known to be activated during positive rein-
forcement (VS) compared with nearby motor regions (DS).
Furthermore, an early rapid increase followed by a later
more persistent elevation in taurine levels was observed,
suggesting a complex release mechanism. Taurine changes
involved a systemic effect of ethanol rather than a local
effect, which argues against this efflux being attributed
solely to osmotic changes caused by local ethanol exposure.
These novel observations were made possible by the first
high temporal resolution monitoring of multiple amino
acids in the brains of freely moving animals using microdi-
alysis coupled to rapid on-line CE-LIF analysis.
Systemic administration of ethanol produced dose-
related biphasic increases in taurine. In the VS, a 2 g/kg
dose of ethanol increased taurine levels almost 2-fold dur-
ing the first 20 min after injection where it remained ele-
vated by 30% for at least 1 hr. The dose-related increase in
taurine seen after injections of the two higher doses of
ethanol confirms previous reports in VS (Dahchour et al.,
1994, 1996). However, the significant dose-related increase
in taurine seen in DS and the increases in both DS and VS
after 0.5 g/kg ethanol have not previously been reported.
Similarly, previous reports did not indicate a biphasic na-
ture of the response of taurine to higher doses of ethanol.
The primary difference between this work and previous
studies is the decrease in sampling interval to 11 sec from
15 min. The conclusion that the 82-fold improvement in
temporal resolution enabled these novel observations is
supported by comparison of data from experiments in
which HPLC analysis failed to detect an effect of 1 g/kg
ethanol in DS that was significantly different from the
saline response. Additionally, the increased statistical
power afforded by the larger number of samples gathered
by CE-LIF, compared with only four samples per hour
collected every 15 min with HPLC techniques, may have
contributed to significant effects observed on exposure to
both 0.5 and 1 g/kg ethanol in DS. Thus, the use of CE-LIF
in freely moving animals allowed for the detection of tau-
rine levels evoked by clinically and behaviorally relevant
doses of ethanol. The effects of the higher dose of ethanol
to increase taurine by 2-fold was also found when an acute
dose of 2.5 g/kg of ethanol was given alone as well as when
2.0 g/kg was given 2 hrs after a 0.5 g/kg injection and 1 hr
after a 1 g/kg injection (Smith et al., 2003b). Additionally,
our preliminary data indicate that self-administered doses
as low as 0.4 g/kg ethanol increase taurine levels in VS by
about 20% as measured by on-line CE-LIF (Smith et al.,
2003a).
The role of taurine in the brain and the regulation of its
efflux have not yet been fully characterized. Taurine is one
of the most abundant amino acids in the brain (see
Huxtable, 1992; Pow et al., 2002), present in neurons as
well as glia (Huxtable, 1989, 1992). Many biological roles
have been proposed for taurine including neurotransmis-
sion, osmoregulation, calcium modulation, membrane sta-
bilization, and antioxidation (Huxtable, 1992; Wright et al.,
1986), all of which might contribute to alterations in extra-
cellular taurine levels. Although only a small percentage of
taurine is found in synaptic vesicles, it has been proposed as
an inhibitory neurotransmitter (Davison and Kaczmarek,
1971; Huxtable, 1992; Okamoto et al., 1983). In support of
this, depolarization of neuronal populations causes taurine
release (Collins and Topiwala, 1974; Kaczmarek and Davi-
son, 1972; Schousboe et al., 1990; Shain and Martin, 1990);
however, this release is Ca2-independent, Cl-dependent,
and lower in magnitude compared with other neurotrans-
mitters (Sánchez-Olea and Pasantes-Morales, 1990; Sc-
housboe et al., 1990). Taurine efflux can also occur via a
swelling-activated channel activated by hypo-osmotic con-
ditions (Bres et al., 2000; Boese et al., 1996). Additionally,
extracellular taurine levels are regulated by the activity of a
high-affinity taurine transporter (Smith et al., 1992). All of
these mechanisms might contribute to altered levels of
extracellular taurine caused by ethanol.
At least a portion of ethanol-induced taurine efflux has
been shown to be due to osmoregulation (Lallemande et
al., 2000; Quertemont et al., 2001, 2003). However, our
data indicating the regional selectivity of ethanol’s effects
argue against this mechanism. Also contrary to the osmo-
regulatory hypothesis is our data that local exposure of the
VS to 50 to 1000 mM ethanol increased taurine by only
10% above baseline, which is much less than the 2-fold
increase seen after the 2 g/kg dose (resulting in 30 mM
dialysate ethanol). Unfortunately, the exact concentrations
of ethanol in the brain from the reverse dialysis experi-
ments are not known but would be assumed to be greater
than 30 mM, especially at the 1000 mM dose. The definitive
evidence for determining whether the mechanism for
ethanol-induced taurine efflux is neuronal or osmotic re-
quires testing whether this efflux is dependent on signaling-
activated calcium and sodium channels or whether it is
more dependent on osmotically activated chloride currents.
These experiments are ongoing.
Current techniques for measurement of the release of
these amino acids in vivo have been called into question
(Timmerman and Westerink, 1997) as only detecting extra-
synaptic glutamate and GABA from nonneuronal origin.
The use of the high temporal resolution CE-LIF method
for measuring extracellular levels of amino acids enables
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detection of transient increases in these substances shown
to be derived almost exclusively from neurogenic release
(Lada et al., 1998). Although our methodology and data
can only imply a neuronal origin, it is likely that ethanol-
induced taurine increases, regardless of the source, have a
neuronal impact. Postsynaptically, taurine stimulates chlo-
ride conductance to hyperpolarize membranes (Okamoto
et al., 1983; Ye et al., 1997), presumably as an agonist at
glycine and GABAA receptors (Boehm et al., 1997; Bureau
and Olsen, 1991; Chattipakorn and McMahon, 2002; Haas
and Hösli, 1973; Han et al., 2001; Horikoshi et al., 1988;
Medina and De Robertis, 1984; Mori et al., 2002; Quinn
and Harris, 1995; Schmieden et al., 1992). Because there is
evidence for expression of both GABAA and glycine recep-
tors in the VS (Martin and Siggins, 2002), taurine might
alter neuronal activity via these receptors after ethanol
exposure.
Given taurine’s proposed role as an inhibitory neuro-
transmitter and our ability to view (in almost real time) a
multitude of amino acids in response to ethanol, the ques-
tion arises of a possible interaction of these neurotransmit-
ter systems. Along these lines, the higher ethanol doses
significantly decreased glutamate, glycine, and serine levels,
a finding that has not before been reported (Dahchour et
al., 1994, 1996; Quertemont et al., 2000). The time course
of these changes indicates that the inhibitory effect of
ethanol occurred after taurine levels were increased by
ethanol. These same decreases in glutamate, serine, and
cysteine were also observed when animals received only
one injection of 2.5 g/kg of ethanol (Smith et al., 2003b)
compared with the cumulative injection scheme used pres-
ently. It will be interesting to test whether the decreases in
these amino acids are dependent on ethanol-induced in-
creases in taurine inhibition.
The effect of the lowest dose of ethanol on glutamate
was much more complicated. In both regions, but particu-
larly in DS, the 0.5 g/kg dose caused a marked elevation in
glutamate levels in only about half of the individual rats
tested for each region. There is only one previous report
that low-dose ethanol administration might increase gluta-
mate in the VS (Moghaddam and Bolinao, 1994) compared
with reports indicating no effect of 1, 2, or 3 g/kg ethanol on
glutamate (e.g., Dahchour et al., 1994, 1996). Instead, in-
creases in glutamate are generally associated with with-
drawal from ethanol (Dahchour et al., 1998; Dahchour and
De Witte, 1999, 2000b, 2003; Quertemont et al., 2002).
Ethanol craving is regulated by its ability to increase
neuronal firing in the mesolimbic dopamine pathway
(Hodge et al., 1997; Koob et al., 1998). This effect of
ethanol does not occur in all dopaminergic pathways, be-
cause ethanol decreases dopamine transmission in DS
(Budygin et al., 2001). Such regional specificity may indi-
cate a relationship between the magnitude of ethanol-
induced taurine efflux and the ability of ethanol to increase
dopamine transmission. Future experiments using CE-LIF
can simultaneously track dopamine and taurine changes on
a high-resolution time scale.
In summary, our novel observations have opened up
several new lines of possible investigation including the
temporal relationship between changes in taurine, dopa-
mine, and glutamate as well as the mechanisms of taurine
release caused by ethanol. The ability of CE-LIF to mea-
sure the temporal relationship between changes in these
neurotransmitters, coupled with its ability to measure sub-
tle changes in neurotransmitter levels in awake animals
self-administering ethanol, should provide a tremendous
opportunity to better understand the alterations in signal-
ing that underlie the development of alcoholism.
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